| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 10838599 | Pharmacology Biochemistry and Behavior | 2005 | 6 Pages |
Abstract
These data show that administration of the synthetic cannabinoid receptor agonist WIN leads to dose-dependent alterations of the performance in an operant behavior task and of motor behavior. We confirm previous findings of dose-dependent motor stimulating and inhibiting effects of cannabinoids, and show an impairment of a complex operant behavior at higher doses of WIN.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Biochemistry
Authors
Eva Drews, Miriam Schneider, Michael Koch,